Oligonucleotide Synthesis Market Trends and Growth Outlook Through 2035
The biopharmaceutical landscape is undergoing a massive shift toward targeted genomic medicine. For decades, small molecules and monoclonal antibodies dominated drug pipelines. However, the rise of antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and messenger RNA (mRNA) technologies has opened up previously "undruggable" disease targets. At the core of every single nucleic...
0 Commentarii 0 Distribuiri 3 Views 0 previzualizare
BuzzingAbout https://www.buzzingabout.com